An An Open-Label Clinical Study to Evaluate the Safety and Antiepileptic Activity of Ganaxolone in Treatment of Patients Diagnosed With Infantile Spasms.

Trial Profile

An An Open-Label Clinical Study to Evaluate the Safety and Antiepileptic Activity of Ganaxolone in Treatment of Patients Diagnosed With Infantile Spasms.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 30 Sep 2017

At a glance

  • Drugs Ganaxolone (Primary)
  • Indications Infantile spasms
  • Focus Therapeutic Use
  • Sponsors Marinus Pharmaceuticals
  • Most Recent Events

    • 28 Apr 2009 Results presented at AAN 2009.
    • 08 Apr 2009 Planned end date changed to 1 Mar 2009 as reported by ClinicalTrials.gov.
    • 08 Apr 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top